HighGravityDataHumana — Oct 30, 2024 release
Fiscal 2024 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000049071-24-000051
Showing in the filing
Cash flows from operations, GAAP
“approximately $2.75 billion”
Period
FY2024
Measure
Company-defined measure
Source
Guidance table
All guidance in this release · 28
EPS, GAAP basis for FY2024
“at least $12.89”
Diluted earnings per share (Adjusted non-GAAP) for FY2024
“at least $16.00”
EPS, Adjusted basis for FY2024
“at least $16.00”
Individual Medicare Advantage annual members… for FY2024
“approximately 265,000, or approximately 5 percent”
Diluted earnings per common share (GAAP) for FY2024
“at least $12.89”
Total Revenues: Consolidated for FY2024
“no change”
Change in year-end medical membership from p… for FY2024
“no change”
Total Revenues, Consolidated, GAAP for FY2024
“approximately $116 billion”
Total Revenues: CenterWell segment for FY2024
“no change”
Benefit Ratio: Insurance segment for FY2024
“no change”
Segment Results: Insurance segment income fr… for FY2024
“no change”
Total Revenues, Insurance segment, GAAP for FY2024
“approximately $112 billion”
Total Revenues, CenterWell segment, GAAP for FY2024
“approximately $19 billion”
Change in year-end medical membership from p… for FY2024
“Growth of approximately 265,000”
Change in year-end medical membership from p… for FY2024
“Growth of approximately 35,000”
Change in year-end medical membership, Medic… for FY2024
“Decline of approximately 600,000”
Change in year-end medical membership from p… for FY2024
“Growth of approximately 200,000”
Benefit Ratio, Insurance segment, GAAP for FY2024
“approximately 90%”
Operating Cost Ratio, Consolidated, GAAP for FY2024
“approximately 11.4%”
Operating Cost Ratio: Consolidated for FY2024
“no change”
Insurance segment income from operations, GAAP for FY2024
“approximately $1.1 billion”
Insurance segment income from operations, No… for FY2024
“approximately $1.2 billion”
CenterWell segment income from operations, N… for FY2024
“approximately $1.4 billion”
Effective Tax Rate, GAAP for FY2024
“approximately 25.2%”
Effective Tax Rate, Non-GAAP for FY2024
“approximately 25.0%”
Weighted Avg. Share Count for Diluted EPS for FY2024
“approximately 121 million”
Cash flows from operations, GAAP for FY2024
“approximately $2.75 billion”
Capital expenditures, GAAP for FY2024
“approximately $600 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
CenterWell segment income from operations no change GAAP: approximately $1.2 billion Non-GAAP: approximately $1.4 billion Effective Tax Rate no change GAAP: approximately 25.2% Non-GAAP: approximately 25.0% Weighted Avg. Share Count for Diluted EPS no change approximately 121 million Cash flows from operations GAAP: approximately $2.75 billion GAAP: approximately $2 billion Capital expenditures GAAP: approximately $600 million GAAP: approximately $800 million 15 Humana Inc. Statistical Schedules and Supplementary Information 3Q24 Earnings Release S-1 Humana Inc. Statistical Schedules and Supplementary Information 3Q24 Earnings Release (S-3) Consolidated Statements of Income - Quarter and YTD (S-4) Consolidated Balance Sheets (S-5) Consolidated Statements of Cash Flows - YTD (S-6) - (S-7) Consolidating Statements of Income - Quarter (S-8) - (S-9) Consolidating Statements of Income - YTD (S-10) Membership Detail (S-11) - (S-12) Premiums and Services Revenue Detail (S-13) - (S-15) CenterWell Segment - Pharmacy Solutions, Primary Care, & Home Solutions (S-16) Footnotes S-2 Humana Inc. Consolidated Statements of Income (Unaudited) Dollars in millions, except per common share results For the three months ended September 30, For the nine months ended September 30, 2024 2023 2024 2023 Revenues: Premiums $ 27,951 $ 25,099 $ 84,354 $ 76,144 Services 1,103 1,016 3,265 2,993 Investment income 343 308 929 775 Total revenues 29,397 26,423 88,548 79,912 Operating expenses: Benefits 25,120 21,745 75,283
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.